![]() |
|
|
Vol. 294, Issue 1, 160-167, July 2000
Institut National de la Santé et de la Recherche
Médicale U456, Détoxication et Réparation Tissulaire,
Faculté des Sciences Pharmaceutiques et Biologiques,
Université de Rennes I, Rennes, France
Tacrine (THA), used in the treatment of Alzheimer's disease, is
known to induce hepatotoxicity, the mechanisms of which remain to be
fully established. We have previously shown that THA reduced intracellular glutathione concentration in rat hepatocytes in primary
culture, thus pointing to a possible role for oxidative stress
in THA toxicity. To test this, the effects of antioxidant molecules,
namely, the flavonoids silibinin, silibinin dihydrogensuccinate, and
silymarin, were evaluated on the toxicity of THA in cultured rat
hepatocytes. This toxicity was investigated after a 24-h treatment over
a concentration range from 0 to 1 mM, in the presence or absence
of antioxidant (1 and 10 µM). We found that simultaneous treatment of
hepatocytes with any of the antioxidants and THA remained
ineffective on the lactate dehydrogenase release induced by THA. Then,
the production of lipid-derived radicals (to estimate lipid
peroxidation) was measured in THA (0.05-0.50 mM)-treated cells using a
spin-trapping technique coupled to electron paramagnetic resonance
(EPR) spectroscopy. No increase of the EPR signal was observed over the
period of 30 min to 24 h. In contrast, treatment of cells with the
spin label 12-doxyl stearic acid followed by EPR spectroscopy showed
that THA (0.05 and 0.25 mM) rapidly increased hepatocyte membrane
fluidity. Extracellular application of GM1 ganglioside (60 µM) both
reversed this increase in fluidity and partially reduced lactate
dehydrogenase release on THA exposure. In conclusion, this work
indicates that early alterations of membrane fluidity, not resulting
from lipid peroxidation, are likely to play an important role in the
development of THA toxicity.
This article has been cited by other articles:
![]() |
J. J. Xu, P. V. Henstock, M. C. Dunn, A. R. Smith, J. R. Chabot, and D. de Graaf Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury Toxicol. Sci., September 1, 2008; 105(1): 97 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rebillard, X. Tekpli, O. Meurette, O. Sergent, G. LeMoigne-Muller, L. Vernhet, M. Gorria, M. Chevanne, M. Christmann, B. Kaina, et al. Cisplatin-Induced Apoptosis Involves Membrane Fluidification via Inhibition of NHE1 in Human Colon Cancer Cells Cancer Res., August 15, 2007; 67(16): 7865 - 7874. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lacour, A. Hammann, S. Grazide, D. Lagadic-Gossmann, A. Athias, O. Sergent, G. Laurent, P. Gambert, E. Solary, and M.-T. Dimanche-Boitrel Cisplatin-Induced CD95 Redistribution into Membrane Lipid Rafts of HT29 Human Colon Cancer Cells Cancer Res., May 15, 2004; 64(10): 3593 - 3598. [Abstract] [Full Text] [PDF] |
||||